Interpretation of postmortem toxicology: More complicated than it might seem - Part 1

Adverse Drug Reaction Bulletin

Volumn , Issue 249, 2008, Pages

  Flanagan, Robert J ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; POISON; POLONIUM;

AGE DISTRIBUTION; ANALYTIC METHOD; AUTOPSY; BLOOD ANALYSIS; BODY FLUID; CLINICAL PHARMACOLOGY; EXPOSURE VARIABLE; FORENSIC TOXICOLOGY; HISTOPATHOLOGY; HUMAN; MOLECULAR WEIGHT; MORTALITY; QUANTITATIVE ANALYSIS; REVIEW; SAMPLING; SELF POISONING; URINALYSIS; VALIDATION PROCESS; VITREOUS BODY;

EID: 85086421121     PISSN: 00446394     EISSN: None     Source Type: Journal    
DOI: 10.1097/fad.0b013e32830ceaea     Document Type: Review

References (19)

1. Drummer OH. Postmortem toxicology. Forensic Science International 2007; 165:199-203.
2. Leikin JB, Watson WA. Postmortem toxicology: what the dead can and cannot tell us. Journal of Toxicology Clinical Toxicology 2003;41:47-56.
3. Gruszecki AC, Booth J, Davis GG. The predictive value of history and scene investigation for toxicology results in a medical examiner population. The American Journal of Forensic Medicine and Pathology 2007; 28:103-106.
4. Drummer OH, Gerostamoulos J. Post-mortem drug analysis: analytical and toxicological aspects. Therapeutic Drug Monitoring 2002; 24:199-209.
5. Skopp G. Preanalytic aspects in post-mortem toxicology. Forensic Science International 2004;142:75-100.
6. Flanagan RJ, Connally G. Interpretation of analytical toxicology results in life and at postmortem. Toxicological Reviews 2005: 24:51-62.
7. Langford AM, Taylor KK, Pounder DJ. Drug concentration in selected skeletal muscles. Journal of Forensic Sciences 1998;43:22-27.
8. Pounder DJ, Adams E, Fuke C, Langford AM. Site to site variability of postmortem drug concentrations in liver and lung. Journal of Forensic Sciences 1996;41:927-932.
9. Forrest ARW. Obtaining samples at postmortem examination for toxicological and biochemical analysis. Journal of Clinical Pathology 1993;46:292-296.
10. Flanagan RJ, Connally G, Evans JM. Analytical toxicology: guidelines for sample collection postmortem. Toxicological Reviews 2005;24:63-71.
11. Pragst F, Balikova MA. State of the art in hair analysis for detection of drug and alcohol abuse. Clinica Chimica Acta 2006;370:17-49.
12. Musshoff F, Madea B. Analytical pitfalls in hair testing. Analytical and Bioanalytical Chemistry 2007;388: 1475-1494.
13. Jannetto PJ, Wong SH, Gock SB, et al. Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: genotyping cytochrome P450 2D6 for oxycodone cases. Journal of Analytical Toxicology 2002;26:438-447.
14. Levo A, Koski A, Ojanpera I, et al. Postmortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood. Forensic Science International 2003;135:9-15.
15. Holmgren P, Carlsson B, Zackrisson AL, et al. Enantioselective analysis of citalopram and its metabolites in post-mortem blood and genotyping for CYD2D6 and CYP2C19. Journal of Analytical Toxicology 2004; 28:94-104.
16. Drummer OH. Requirements for bioanalytical procedures in postmortem toxicology. Analytical and Bioanalytical Chemistry 2007; 388:1495-1503.
17. Flanagan RJ, Whelpton R. Quality Management. In: Encyclopedia of Forensic Science. Chichester: Wiley, 2009 (in press).
18. Peters FT, Drummer OH, Musshoff F. Validation of new methods. Forensic Science International 2007; 165:216-224.
19. Spiehler VR, Fischer WR, Richards RG. Digoxin-like immunoreactive substance in postmortem blood of infants and children. Journal of Forensic Sciences 1985; 30:86-91.